Physician profile

Amit Tibrewala

Cardiovascular Disease · Cumming, GA

NPI 1720275233

$6,698.36

in general payments reported to CMS, 2019-2025

33 companies · $512 in 2025

The $512 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,743.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $897.72 2019-2024 Lifevest
Amgen INC. $722.36 2019-2025 Repatha, Repatha
Boehringer Ingelheim Pharmaceuticals, INC. $679.40 2019-2025 Jardiance
Janssen Pharmaceuticals, INC $562.67 2019-2022
E.R. Squibb & Sons, L.L.C. $500.48 2019-2025 Camzyos, Eliquis
Novartis Pharmaceuticals Corporation $419.00 2019-2025
Esperion Therapeutics, INC. $381.64 2021-2025 Nexletol
Merck Sharp & Dohme LLC $340.00 2021-2025 Verquvo
Boston Scientific Corporation $230.92 2019-2023 Watchman Flx, Watchman Access System
Pfizer INC. $166.50 2019-2025
Actelion Pharmaceuticals US, INC. $154.09 2019-2021
Heartflow, INC. $145.97 2023-2025 Ffrct
Medtronic Vascular, INC. $142.70 2019
Medtronic, INC. $141.35 2023 Micra
Janssen Scientific Affairs, LLC $132.80 2024 Xarelto
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $128.60 2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Astellas Pharma US INC $117.72 2019
Nuwellis, INC. $115.62 2019
Astrazeneca Pharmaceuticals LP $115.44 2021-2024 Wainua
Sanofi-Aventis U.S. LLC $93.82 2019-2021
Amarin Pharma, INC. $87.24 2019-2021
Kestra Medical Technology Services, INC. $62.24 2024 Assure Wcd
Kiniksa Pharmaceuticals International, Plc $55.82 2024 Arcalyst
Edwards Lifesciences Corporation $51.97 2019-2020
Lantheus Medical Imaging, INC. $42.99 2021-2024
Kiniksa Pharmaceuticals, LTD. $38.77 2023 Arcalyst
Cvrx, INC. $36.33 2023 Barostim Neo System
Chiesi USA, INC. $33.51 2019-2021
Bayer Healthcare Pharmaceuticals INC. $29.61 2021-2025
Abbott Laboratories $25.00 2021
Novo Nordisk INC $19.84 2022
Amryt Pharma Holdings LTD $13.90 2021
Kowa Pharmaceuticals America, INC. $12.34 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amit Tibrewala

$6,698.36

in general payments reported 2019-2025

Years
2019-2025
Top company
Zoll Services LLC (A/K/A Zoll Lifecor Corp)
Context
The $512 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/1209749/amit-tibrewala

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.